Feedback / Questions
soquelitinib (CPI-818) - Corvus Pharma
https://www.globenewswire.com/news-release/2026/08/27/3351916/0/en/corvus-pharmaceuticals-announces-publication-in-blood-of-final-phase-1-data-from-the-soquelitinib-phase-1-1b-t-cell-lymphoma-trial.html
Aug 27, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next